Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study was to determine whether TH9507, a stabilized analogue of growth hormone-releasing factor (GRF), would have an effect on insulin sensitivity or control of diabetes in patients with type 2 diabetes.
Epistemonikos ID: d9a99e16c728cbcd082a07ca4905dd4d207bdc79
First added on: May 06, 2024